Literature DB >> 24099015

Drug-induced cholestasis.

Kalyan Ram Bhamidimarri1, Eugene Schiff.   

Abstract

Drug-induced cholestasis manifests as an acute self-limiting injury or as a chronic perpetuating injury, resulting in duct loss and cirrhosis. The number of drugs implicated in drug-induced cholestasis grows every year as new drugs are developed and approved. Other agents such as herbals, nutritional supplements, and complementary and alternative medicines are also reported to cause cholestatic liver injury. Recent literature on molecular transporters involved in bile transport has improved our understanding of patterns of drug-induced liver injury and the mechanisms of cholestasis. This article summarizes the probable offending drugs, and the diagnosis and management of drug-induced cholestasis.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bile duct injury; Cholestasis; Drugs; Liver injury; Management

Mesh:

Year:  2013        PMID: 24099015     DOI: 10.1016/j.cld.2013.07.015

Source DB:  PubMed          Journal:  Clin Liver Dis        ISSN: 1089-3261            Impact factor:   6.126


  9 in total

1.  Population Scale Retrospective Analysis Reveals Potential Risk of Cholestasis in Pregnant Women Taking Omeprazole, Lansoprazole, and Amoxicillin.

Authors:  Yonghong Zhang; Da Shi; Ruben Abagyan; Weina Dai; Mingyang Dong
Journal:  Interdiscip Sci       Date:  2019-05-20       Impact factor: 2.233

2.  Activation of Constitutive Androstane Receptor (CAR) in Mice Results in Maintained Biliary Excretion of Bile Acids Despite a Marked Decrease of Bile Acids in Liver.

Authors:  Andrew J Lickteig; Iván L Csanaky; Matthew Pratt-Hyatt; Curtis D Klaassen
Journal:  Toxicol Sci       Date:  2016-03-16       Impact factor: 4.849

3.  Industrial, Biocide, and Cosmetic Chemical Inducers of Cholestasis.

Authors:  Vânia Vilas-Boas; Eva Gijbels; Axelle Cooreman; Raf Van Campenhout; Emma Gustafson; Kaat Leroy; Mathieu Vinken
Journal:  Chem Res Toxicol       Date:  2019-06-18       Impact factor: 3.739

4.  Synthesis, Spectroscopic Studies for Five New Mg (II), Fe (III), Cu (II), Zn (II) and Se (IV) Ceftriaxone Antibiotic Drug Complexes and Their Possible Hepatoprotective and Antioxidant Capacities.

Authors:  Samy M El-Megharbel; Safa H Qahl; Fatima S Alaryani; Reham Z Hamza
Journal:  Antibiotics (Basel)       Date:  2022-04-20

5.  In vitro prediction of drug-induced cholestatic liver injury: a challenge for the toxicologist.

Authors:  Mathieu Vinken
Journal:  Arch Toxicol       Date:  2018-03-24       Impact factor: 5.153

Review 6.  Drug-induced cholestasis.

Authors:  Vinay Sundaram; Einar S Björnsson
Journal:  Hepatol Commun       Date:  2017-09-11

Review 7.  Rodent models of cholestatic liver disease: A practical guide for translational research.

Authors:  Eva Gijbels; Alanah Pieters; Kevin De Muynck; Mathieu Vinken; Lindsey Devisscher
Journal:  Liver Int       Date:  2021-02-23       Impact factor: 5.828

8.  Hierarchy-Assembled Dual Probiotics System Ameliorates Cholestatic Drug-Induced Liver Injury via Gut-Liver Axis Modulation.

Authors:  Qi-Wen Chen; Qian-Ru Li; Meng-Wei Cao; Jian-Hua Yan; Xian-Zheng Zhang
Journal:  Adv Sci (Weinh)       Date:  2022-04-17       Impact factor: 17.521

9.  Kinsenoside Alleviates 17α-Ethinylestradiol-Induced Cholestatic Liver Injury in Rats by Inhibiting Inflammatory Responses and Regulating FXR-Mediated Bile Acid Homeostasis.

Authors:  Jiaxiong Ming; Qianqian Xu; Limin Gao; Yanfang Deng; Jie Yin; Qun Zhou; Qingyi Tong; Yonghui Zhang
Journal:  Pharmaceuticals (Basel)       Date:  2021-05-11
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.